Buscar resultados de ensayos clínicos
Neurotoxicity Syndromes - 25 Studies Found
Estado | Estudiar |
Terminated |
Nombre del estudio: A Pilot Study of Dextromethorphan for the Prevention and Treatment of Methotrexate Neurotoxicity Condición: Neurotoxicity Syndromes Fecha: 2005-09-12 Intervenciones: Drug: Dextromethorphan Patients will receive an inert carrier with or without dextromethorphan. The stud |
Recruiting |
Nombre del estudio: To Study the Individual Variants of Chemotherapy-Induced Neurotoxicity Condición: Neurotoxicity Syndromes Fecha: 2015-06-09 Intervenciones:
|
Recruiting |
Nombre del estudio: Monosialoganglioside Preventing Neurotoxicity Induced by Albumin-bound Paclitaxel Chemotherapy in Lung Cancer Patients Condición: Neurotoxicity Fecha: 2015-07-11 Intervenciones: Drug: monosialoganglioside 40mg in the vein on day 1 - day 8 of each 21 days cycle. Number of Cycles: 2 |
Terminated |
Nombre del estudio: Study to Assess Prevention of Oxaliplatin-induced Neurotoxicity Through Vitamin D Pathway Condición: Neurotoxicity Fecha: 2011-10-18 Intervenciones: Drug: Vitamin D3 Vitamin D3 will be administered at a dose of 2000 IU orally daily starting on day 1 of |
Recruiting |
Nombre del estudio: Monosialotetrahexosylganglioside for Treatment of Oxaliplatin Induced Neurotoxicity in Gastrointestinal Cancer Condición: Neurotoxicity Fecha: 2015-05-03 Intervenciones:
|
Completed |
Nombre del estudio: Protective Effect of Mangafodipir Against Oxaliplatin Neurotoxicity Condición:
Fecha: 2008-07-31 Intervenciones: Drug: Mangafodipir Mangafodipir (0.5 ml/kg) is administered as a 30 minutes infusion just after each adm |
Completed |
Nombre del estudio: Calcium Gluconate and Magnesium Sulfate in Preventing Neurotoxicity Caused By Oxaliplatin in Patients Receiving Combination Chemotherapy for Stage II, Stage III, or Stage IV Colorectal Cancer That Has Been Completely Removed By Surgery Condición:
Fecha: 2006-04-19 Intervenciones:
|
Completed |
Nombre del estudio: Biomarkers in Predicting Neurotoxicity in Patients With Colorectal Cancer Receiving Oxaliplatin Condición:
|
Withdrawn |
Nombre del estudio: Scopolamine Treatment for Patients With Organophosphate Poisoning Condición: Neurotoxicity Syndromes Fecha: 2006-10-17 Intervenciones: Drug: Placebo IV placebo q4h |
Completed |
Nombre del estudio: Calcium Gluconate and Magnesium Sulfate in Preventing Neurotoxicity in Patients With Colon Cancer or Rectal Cancer Receiving Oxaliplatin-Based Combination Chemotherapy Condición:
|